1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 BMS-906024 1.2.3 Buparlisib Hydrochloride 1.2.4 FP-1039 1.2.5 Ipilimumab 1.2.6 JNJ-42756493 1.2.7 Lenvatinib 1.2.8 Others 1.3 Market by Application 1.3.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Research Center 1.3.3 Hospital 1.3.4 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Perspective (2016-2027) 2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions 2.2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Dynamic 2.3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends 2.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers 2.3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges 2.3.4 Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue 3.1.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue 3.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio 3.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2020 3.5 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served 3.6 Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service 3.7 Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Type 4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) 5 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Application 5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027) 6.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type 6.2.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027) 6.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application 6.3.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027) 6.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country 6.4.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027) 7.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type 7.2.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027) 7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application 7.3.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027) 7.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country 7.4.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type 8.2.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application 8.3.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region 8.4.1 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027) 9.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type 9.2.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application 9.3.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country 9.4.1 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type 10.2.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application 10.3.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country 10.4.1 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Ascenta Therapeutics, Inc. 11.1.1 Ascenta Therapeutics, Inc. Company Details 11.1.2 Ascenta Therapeutics, Inc. Business Overview 11.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.1.4 Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.1.5 Ascenta Therapeutics, Inc. Recent Development 11.2 AstraZeneca Plc 11.2.1 AstraZeneca Plc Company Details 11.2.2 AstraZeneca Plc Business Overview 11.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.2.4 AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.2.5 AstraZeneca Plc Recent Development 11.3 AVEO Pharmaceuticals, Inc. 11.3.1 AVEO Pharmaceuticals, Inc. Company Details 11.3.2 AVEO Pharmaceuticals, Inc. Business Overview 11.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.3.4 AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.3.5 AVEO Pharmaceuticals, Inc. Recent Development 11.4 Bayer AG 11.4.1 Bayer AG Company Details 11.4.2 Bayer AG Business Overview 11.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.4.4 Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.4.5 Bayer AG Recent Development 11.5 BIND Therapeutics, Inc. 11.5.1 BIND Therapeutics, Inc. Company Details 11.5.2 BIND Therapeutics, Inc. Business Overview 11.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.5.4 BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.5.5 BIND Therapeutics, Inc. Recent Development 11.6 Boehringer Ingelheim GmbH 11.6.1 Boehringer Ingelheim GmbH Company Details 11.6.2 Boehringer Ingelheim GmbH Business Overview 11.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.6.4 Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.6.5 Boehringer Ingelheim GmbH Recent Development 11.7 Bristol-Myers Squibb Company 11.7.1 Bristol-Myers Squibb Company Company Details 11.7.2 Bristol-Myers Squibb Company Business Overview 11.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.7.4 Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.7.5 Bristol-Myers Squibb Company Recent Development 11.8 Eli Lilly and Company 11.8.1 Eli Lilly and Company Company Details 11.8.2 Eli Lilly and Company Business Overview 11.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.8.4 Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.8.5 Eli Lilly and Company Recent Development 11.9 F. Hoffmann-La Roche Ltd. 11.9.1 F. Hoffmann-La Roche Ltd. Company Details 11.9.2 F. Hoffmann-La Roche Ltd. Business Overview 11.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.9.5 F. Hoffmann-La Roche Ltd. Recent Development 11.10 Five Prime Therapeutics, Inc. 11.10.1 Five Prime Therapeutics, Inc. Company Details 11.10.2 Five Prime Therapeutics, Inc. Business Overview 11.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.10.4 Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.10.5 Five Prime Therapeutics, Inc. Recent Development 11.11 Genentech, Inc. 11.11.1 Genentech, Inc. Company Details 11.11.2 Genentech, Inc. Business Overview 11.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.11.4 Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.11.5 Genentech, Inc. Recent Development 11.12 Incyte Corporation 11.12.1 Incyte Corporation Company Details 11.12.2 Incyte Corporation Business Overview 11.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.12.4 Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.12.5 Incyte Corporation Recent Development 11.13 Johnson & Johnson 11.13.1 Johnson & Johnson Company Details 11.13.2 Johnson & Johnson Business Overview 11.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.13.4 Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.13.5 Johnson & Johnson Recent Development 11.14 MacroGenics, Inc. 11.14.1 MacroGenics, Inc. Company Details 11.14.2 MacroGenics, Inc. Business Overview 11.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.14.4 MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.14.5 MacroGenics, Inc. Recent Development 11.15 Novartis AG 11.15.1 Novartis AG Company Details 11.15.2 Novartis AG Business Overview 11.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.15.4 Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.15.5 Novartis AG Recent Development 11.16 Oncogenex Pharmaceuticals, Inc. 11.16.1 Oncogenex Pharmaceuticals, Inc. Company Details 11.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview 11.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.16.4 Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.16.5 Oncogenex Pharmaceuticals, Inc. Recent Development 11.17 PsiOxus Therapeutics Limited 11.17.1 PsiOxus Therapeutics Limited Company Details 11.17.2 PsiOxus Therapeutics Limited Business Overview 11.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 11.17.4 PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) 11.17.5 PsiOxus Therapeutics Limited Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of BMS-906024 Table 3. Key Players of Buparlisib Hydrochloride Table 4. Key Players of FP-1039 Table 5. Key Players of Ipilimumab Table 6. Key Players of JNJ-42756493 Table 7. Key Players of Lenvatinib Table 8. Key Players of Others Table 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2016-2021) Table 13. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027) Table 15. Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends Table 16. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers Table 17. Squamous Non-Small Cell Lung Cancer Therapeutics Market Challenges Table 18. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints Table 19. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players (2016-2021) Table 21. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2020) Table 22. Ranking of Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service Table 26. Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 29. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021) Table 30. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2016-2021) Table 34. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 37. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 39. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 66. Ascenta Therapeutics, Inc. Company Details Table 67. Ascenta Therapeutics, Inc. Business Overview Table 68. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 69. Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 70. Ascenta Therapeutics, Inc. Recent Development Table 71. AstraZeneca Plc Company Details Table 72. AstraZeneca Plc Business Overview Table 73. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 74. AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 75. AstraZeneca Plc Recent Development Table 76. AVEO Pharmaceuticals, Inc. Company Details Table 77. AVEO Pharmaceuticals, Inc. Business Overview Table 78. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 79. AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 80. AVEO Pharmaceuticals, Inc. Recent Development Table 81. Bayer AG Company Details Table 82. Bayer AG Business Overview Table 83. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 84. Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 85. Bayer AG Recent Development Table 86. BIND Therapeutics, Inc. Company Details Table 87. BIND Therapeutics, Inc. Business Overview Table 88. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 89. BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 90. BIND Therapeutics, Inc. Recent Development Table 91. Boehringer Ingelheim GmbH Company Details Table 92. Boehringer Ingelheim GmbH Business Overview Table 93. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 94. Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 95. Boehringer Ingelheim GmbH Recent Development Table 96. Bristol-Myers Squibb Company Company Details Table 97. Bristol-Myers Squibb Company Business Overview Table 98. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 99. Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 100. Bristol-Myers Squibb Company Recent Development Table 101. Eli Lilly and Company Company Details Table 102. Eli Lilly and Company Business Overview Table 103. Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 104. Eli Lilly and Company Recent Development Table 105. F. Hoffmann-La Roche Ltd. Company Details Table 106. F. Hoffmann-La Roche Ltd. Business Overview Table 107. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 108. F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 109. F. Hoffmann-La Roche Ltd. Recent Development Table 110. Five Prime Therapeutics, Inc. Company Details Table 111. Five Prime Therapeutics, Inc. Business Overview Table 112. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 113. Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 114. Five Prime Therapeutics, Inc. Recent Development Table 115. Genentech, Inc. Company Details Table 116. Genentech, Inc. Business Overview Table 117. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 118. Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 119. Genentech, Inc. Recent Development Table 120. Incyte Corporation Company Details Table 121. Incyte Corporation Business Overview Table 122. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 123. Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 124. Incyte Corporation Recent Development Table 125. Johnson & Johnson Company Details Table 126. Johnson & Johnson Business Overview Table 127. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 128. Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 129. Johnson & Johnson Recent Development Table 130. MacroGenics, Inc. Company Details Table 131. MacroGenics, Inc. Business Overview Table 132. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 133. MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 134. MacroGenics, Inc. Recent Development Table 135. Novartis AG Company Details Table 136. Novartis AG Business Overview Table 137. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 138. Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 139. Novartis AG Recent Development Table 140. Oncogenex Pharmaceuticals, Inc. Company Details Table 141. Oncogenex Pharmaceuticals, Inc. Business Overview Table 142. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 143. Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 144. Oncogenex Pharmaceuticals, Inc. Recent Development Table 145. PsiOxus Therapeutics Limited Company Details Table 146. PsiOxus Therapeutics Limited Business Overview Table 147. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product Table 148. PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) & (US$ Million) Table 149. PsiOxus Therapeutics Limited Recent Development Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. BMS-906024 Features Figure 3. Buparlisib Hydrochloride Features Figure 4. FP-1039 Features Figure 5. Ipilimumab Features Figure 6. JNJ-42756493 Features Figure 7. Lenvatinib Features Figure 8. Others Features Figure 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2027 Figure 10. Research Center Case Studies Figure 11. Hospital Case Studies Figure 12. Clinic Case Studies Figure 13. Squamous Non-Small Cell Lung Cancer Therapeutics Report Years Considered Figure 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2027 Figure 17. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2022-2027) Figure 18. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players in 2020 Figure 19. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2020 Figure 21. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2016-2021) Figure 22. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2022-2027) Figure 23. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027) Figure 25. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027) Figure 26. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027) Figure 27. United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027) Figure 31. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027) Figure 32. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027) Figure 33. Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027) Figure 41. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027) Figure 42. Asia-Pacific Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Region (2016-2027) Figure 43. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027) Figure 51. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027) Figure 52. Latin America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027) Figure 53. Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2016-2027) Figure 57. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2016-2027) Figure 58. Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Country (2016-2027) Figure 59. Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Ascenta Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 63. AstraZeneca Plc Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 64. AVEO Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 65. Bayer AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 66. BIND Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 67. Boehringer Ingelheim GmbH Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 69. Eli Lilly and Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 70. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 71. Five Prime Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 72. Genentech, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 73. Incyte Corporation Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 74. Johnson & Johnson Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 75. MacroGenics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 76. Novartis AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 77. Oncogenex Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 78. PsiOxus Therapeutics Limited Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Ascenta Therapeutics, Inc. AstraZeneca Plc AVEO Pharmaceuticals, Inc. Bayer AG BIND Therapeutics, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd. Five Prime Therapeutics, Inc. Genentech, Inc. Incyte Corporation Johnson & Johnson MacroGenics, Inc. Novartis AG Oncogenex Pharmaceuticals, Inc. PsiOxus Therapeutics Limited